Patent US3931400A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3931400A Expired / Lapsed US ⏱️ 0.0 years remaining

Fortimicin B and process for production thereof

Assignee: Abbott Laboratories
•
Filing: 1974-04-05
•
Granted: 1976-01-06
•
Expires: 1994-04-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new antibiotic, Fortimicin B, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.

Inventors

  • 👤 Takashi Nara
  • 👤 Seigo Takasawa
  • 👤 Ryo Okachi
  • 👤 Isao Kawamoto
  • 👤 Mitsuyoshi Yamamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 23:52
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/22; C07H15/222; C07H15/224; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/863

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 69 words
A composition of matter having antibiotic activity characterized by: a. molecular weight of 348; b. molecular formula of C 15 H 32 N 4 O 5 ; c. an ultraviolet absorption spectrum essentially as shown in FIG. 1; d. an infrared absorption spectrum essentially as shown in FIG. 2; and e. a nuclear magnetic reasonance spectrum essentially as shown in FIG. 3. said composition of matter being Fortimicin B.
Claim 2
Dependent Claim 69 words
A composition of matter having antibiotic activity characterized by: a. molecular weight of 348; b. molecular formula of C 15 H 32 N 4 O 5 ; c. an ultraviolet absorption spectrum essentially as shown in FIG. 1; d. an infrared absorption spectrum essentially as shown in FIG. 2; and e. a nuclear magnetic reasonance spectrum essentially as shown in FIG. 3. said composition of matter being Fortimicin B.
Claim 3
Dependent Claim 45 words
A pharmaceutically acceptable, non-toxic acid addition salt of the composition of matter of claim 1, said acid addition salt being selected from the group consisting of the hydrochloride, hydrobromide, hydroiodide, sulfate, sulfamate, phosphate, maleate, acetate, citrate, oxalate, succinate, benzoate, tartrate, fumarate, malate, mandelate and ascorbate.
Claim 4
Dependent Claim 67 words
A process for producing the antibiotic Fortimicin B which comprises culturing a microorganism selected from the group consisting of Micromonospora olivoasterospora ATCC 21819, Micromonospora olivoasterospora ATCC 31009 and Micromonospora olivoasterospora ATCC 31010 in a nutrient medium containing assimilable sources of carbon and nitrogen at 25° to 40°C. and at about neutral pH until substantial antibacterial activity is detected in the culture liquor and thereafter isolating Fortimicin B.
Claim 5
Dependent Claim 67 words
A process for producing the antibiotic Fortimicin B which comprises culturing a microorganism selected from the group consisting of Micromonospora olivoasterospora ATCC 21819, Micromonospora olivoasterospora ATCC 31009 and Micromonospora olivoasterospora ATCC 31010 in a nutrient medium containing assimilable sources of carbon and nitrogen at 25° to 40°C. and at about neutral pH until substantial antibacterial activity is detected in the culture liquor and thereafter isolating Fortimicin B.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-01-05 1979-07-07 1980-01-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-01-05 1983-07-07 1984-01-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-01-05 1987-07-07 1988-01-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag